Advanced Biosensors for Screening Medicinal Natural Products

A special issue of Biosensors (ISSN 2079-6374). This special issue belongs to the section "Biosensors and Healthcare".

Deadline for manuscript submissions: 28 February 2027 | Viewed by 1075

Editors


E-Mail Website
Guest Editor
Institute of Chemistry, Chinese Academy of Sciences (CAS), Beijing, China
Interests: label-free biosensing and imaging; single-molecule imaging; cell analysis
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
School of Pharmacy, Henan Medical University, Xinxiang 453003, China
Interests: neuropharmacology; severe mental disorders with comorbid physical conditions

Special Issue Information

Dear Colleagues,

Natural products, ranging from large biomolecules such as peptides to small molecules like artemisinin, represent an essential resource for drug development and a prolific source of future therapeutics. However, medicinal natural products often exist at low concentrations and exhibit dynamic changes in composition, posing significant challenges for their detection and characterization. Label-free detection approaches offer a promising solution by enabling analysis under native conditions while minimally perturbing the local environment, thereby preserving the integrity of the target molecules. These attributes make label-free techniques particularly well-suited for screening medicinal natural products within complex biological matrices. Moreover, label-free biosensors provide a powerful tool for in situ screening within isolation platforms, delivering real-time feedback that facilitate the dynamic optimization of separation protocols. In recent years, substantial advances have been made in label-free detection technologies. Notably, the integration of artificial intelligence (AI) with label-free biosensors has significantly enhanced the ability to interpret the rich, multidimensional data generated by these methods, improving both precision and throughput. Despite this progress, there remains a growing demand for the development of novel label-free sensing strategies that are cost-effective, user-friendly and compatible with widely used platforms such as commercial microscopy and existing label-free biosensors for natural product screening. In parallel, the incorporation of tailored AI models continues to be a critical frontier for advancing the field. This Special Issue, entitled “Screening Medicinal Natural Products under Native Conditions”, aims to highlight recent advances in the development of highly sensitive label-free biosensors and their applications in the detection, analysis and screening of natural products, with particular emphasis on approaches that preserve native conditions. We invite original research articles and comprehensive reviews that push the boundaries of label-free biosensor technologies and contribute to the evolving landscape of medicinal natural product discovery.

Dr. Pengfei Zhang
Prof. Dr. Ying Zhao
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biosensors is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • natural products
  • drug screening
  • native conditions
  • biosensors
  • artificial intelligence

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

37 pages, 14116 KB  
Review
Research Progress and Screening Strategies of Natural Product-Derived Neuraminidase Inhibitors
by Jun Duan, Xinjie Guo, Pinghua Sun, Haibo Zhou and Xiangjiu He
Biosensors 2026, 16(7), 365; https://doi.org/10.3390/bios16070365 - 3 Jul 2026
Viewed by 800
Abstract
Seasonal epidemics and high variability of influenza viruses pose a severe threat to global public health security. Neuraminidase, a key functional enzyme in the life cycle of influenza viruses, represents an important target for anti-influenza drug development. Given the continuous emergence of drug-resistant [...] Read more.
Seasonal epidemics and high variability of influenza viruses pose a severe threat to global public health security. Neuraminidase, a key functional enzyme in the life cycle of influenza viruses, represents an important target for anti-influenza drug development. Given the continuous emergence of drug-resistant strains against first-line clinical neuraminidase inhibitors (NAIs) such as oseltamivir, there is an urgent need to develop novel, broad-spectrum, and resistance-overcoming NAIs. Natural products, characterized by structural diversity and a wide range of biological activities, provide abundant resources for the discovery of new NAIs. Recent advances in computer-aided drug design, intelligent analytical platforms, and modern screening technologies have accelerated the identification of natural product-derived NAIs. In particular, biosensor-based strategies, including electrochemical, fluorescence, bioluminescence, and surface-enhanced Raman scattering biosensors, have demonstrated significant advantages in sensitivity, selectivity, rapid response, and high-throughput screening. In combination with computational methods and experimental approaches such as affinity ultrafiltration and activity-guided separation, these technologies have promoted the development of intelligent, precise, and multimodal screening platforms. Looking forward, the integration of biosensor-based high-throughput screening platforms with artificial intelligence algorithms is expected to drive the next generation of natural product screening platforms and facilitate the efficient discovery and clinical translation of novel NAIs. This paper systematically reviews the research progress of screening strategies for natural product-derived NAIs; introduces representative natural active NAIs, including phenols, terpenoids, and alkaloids; and prospects future development directions, aiming to provide a scientific reference for the efficient discovery of NAIs from natural products. Full article
(This article belongs to the Special Issue Advanced Biosensors for Screening Medicinal Natural Products)
Show Figures

Figure 1

Back to TopTop